Displaying 1 - 18 of 18
| Active Ingredient | CALCIUM CARBONATE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | Osteop orosis; intravenous injection - 10ml of 10% after cardiac arrest (asystole), tetany , leg cramps. |
| Caution | Arrhythmias, hypertension, constipation, venous thrombosis, lethargy and muscle weakness. |
| Dose Range | Oral: Tabs.; 0.6-3g daily ; i.v., 1-2g single dose. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CALCIUM CHLORIDE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | Osteoporosis; intravenous injection - 10ml of 10% after cardiac arrest (asystole), tetany, leg cramps. |
| Caution | Arrhythmias, hypertension, constipation, venous thrombosis, lethargy and muscle weakness. |
| Dose Range | Oral: Tabs.; 0.6-3g daily; i.v., 1-2g single dose. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CALCIUM GLUCONATE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | Osteoporosis; intravenous injection - 10ml of 10% after cardiac arrest (asystole), tetany, leg cramps. |
| Caution | Arrhythmias, hypertension, constipation, venous thrombosis, lethargy and muscle weakness. |
| Dose Range | Oral: Tabs.; 0.6-3g daily; i.v., 1-2g single dose. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CALCIUM LACTATE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | Osteoporosis; intravenous injection - 10ml of 10% after cardiac arrest (asystole), tetany, leg cramps. |
| Caution | Arrhythmias, hypertension, constipation, venous thrombosis, lethargy and muscle weakness. |
| Dose Range | Oral: Tabs.; 0.6-3g daily; i.v., 1-2g single dose. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CHROMIUM |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | COPPER |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ELECTROLYTES |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MANGANESE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | Deficiency states |
| Caution | Use cautiously in patients with reduced biliary excretion and cholestatic liver disease. |
| Dose Range | Daily doses ranging from 150 to 800 micrograms. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PLASMA PROTEIN |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | POTASSIUM CHLORIDE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | Patients on loop diuretics or thiazides if, they have a low p otassium diet, are on digoxin, are on steroids, have cirrhosis, have diarrhoea and their measured serum p otassium is less than 3.2 mol/li More ... |
| Caution |
Exercise care in renal failure. Nausea, vomiting,diarrhea, flatulence. c.f. prescribing in renal disease p. 35.. |
| Dose Range |
1-2 tablets daily in divided doses.i.v.20 mmol in 500 mL over 2-3 hours under ECG control; max. dose 2-3 mmol/kg of potassium in 24 hours. Take with food and fluids. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | POTASSIUM CITRATE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | POTASSIUM IODIDE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | POTASSIUM PHOSPHATE |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | REHYDRATION SALTS |
| Therapeutic Class | REPLACEMENT THERAPY |
| Indications | Depletion of salts and fluid in severe diarrhoea. |
| Caution | Adult: 200-400ml of solution after each loose bowel movement. Infant: 1-1 1/2 times usual feed volume; Pediatric: 200ml after each loose stool. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | POTASSIUM-REMOVING RESINS |
| Therapeutic Class | ION REMOVING AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CALCIUM POLYSTYRENE SULPHONATE |
| Therapeutic Class | POTASSIUM-REMOVING AGENTS |
| Indications | Hyperkalemia. |
| Caution | Avoid in hyperparathy roidism, multiple myeloma, sarcoidosis or metastatic carcinoma. Do not dissolve powder in fruit juice which has a high K+ content. S hould not be given by the oral route to ne More ... |
| Dose Range | 15g 3-4 times daily in water. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BRINZOLAMIDE |
| Therapeutic Class | EENT CARBONIC ANHYDRASE INHIBITORS |
| Indications | Reduction of intra-ocular pressure in ocular hypertension and open-angle glaucoma. |
| Caution | Dry mouth, headache, ocular disturbances. |
| Dose Range | Adult: 1-2 drop s 2-3 times daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DORZOLAMIDE |
| Therapeutic Class | EENT CARBONIC ANHYDRASE INHIBITORS |
| Indications | Management of open-angle glaucoma, pseudo-exfoliative glaucoma, and ocular hypertension, either alone or as an adjunct to a topical beta blocker. |
| Caution | Bitter taste, headache, asthenia, ocular irritation, blurred vision, lacrimation, conjunctivitis. |
| Dose Range | Adult: 1-2 drops 3 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |